Overview

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

Status:
Not yet recruiting
Trial end date:
2020-06-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of CKD-375.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical